| |
| |
|
| Insider
Information: |
Grund Nicholas |
| Relationship: |
|
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
388,105 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,581,590 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
388,105 |
|
|
| Total
Value |
$1,581,590 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
AMAG Pharmaceuticals Inc |
AMAG |
Chief Commercial Officer |
2019-03-02 |
84,805 |
2016-01-04 |
0 |
Premium* |
|
|
Akebia Therapeutics, Inc. |
AKBA |
|
2024-01-31 |
303,300 |
2024-01-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AKBA |
Akebia Therapeutics, Inc. |
Chief Commercial Officer |
• – – |
2024-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
303,300 |
303,300 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Chief Commercial Officer |
• – – |
2019-03-02 |
4 |
D |
$14.76 |
$14,494 |
D/D |
(982) |
84,805 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Chief Commercial Officer |
• – – |
2019-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
85,787 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Chief Commercial Officer |
• – – |
2019-02-23 |
4 |
D |
$15.51 |
$15,231 |
D/D |
(982) |
61,787 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Chief Commercial Officer |
• – – |
2019-01-04 |
4 |
D |
$16.19 |
$57,555 |
D/D |
(3,555) |
62,769 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Chief Commercial Officer |
• – – |
2018-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
22,000 |
70,517 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Chief Commercial Officer |
• – – |
2018-03-02 |
4 |
D |
$21.00 |
$88,053 |
D/D |
(4,193) |
66,324 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Chief Commercial Officer |
• – – |
2017-05-08 |
4 |
D |
$18.55 |
$64,610 |
D/D |
(3,483) |
48,517 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Chief Commercial Officer |
• – – |
2016-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
32,000 |
32,000 |
0 |
- |
|
9 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
